Intermap Technologies Corp (IMP)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 0.800 |
|---|---|
| 52-week range | 0.760 – 3.120 |
| Return, 1 month / 3 months | −10.1% / −20.0% |
| Return, 1 year / 3 years | −70.0% / +42.9% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 81.5% |
| Worst drawdown (1 year) | -74.8% |
| Average daily value traded | 0.05M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Intermap Technologies Corp is a geospatial information company based in Calgary, Alberta. It creates three-dimensional terrain elevation data and mapping products, gathering imagery and elevation measurements and turning them into digital models of the land surface. Its customers include government mapping and defence agencies, insurers, engineers and aviation and telecommunications firms that need accurate terrain information for planning, risk assessment and navigation. The company licenses these datasets and related software and services to users around the world.
On this site Intermap Technologies Corp appears as a stock on the Toronto Exchange (Canada), code IMP, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Intermap Technologies Corp (IMP) trades on the Toronto Exchange in Canada. It last closed at CAD 0.800 on 19 October 2026.
Its price-based Market X-Ray is 8 out of 100 (a weak price profile), ranking 856 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 70.0% and over the last three months it fell 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -40.6% | ||
| From 52-week high | -73.8% | ||
| Momentum | 5 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.0% | ||
| 6-month return | -61.9% | ||
| 12-month return, skipping the last month | -66.7% | ||
| Stability (higher is calmer) | 8 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 81.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -74.8% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.9% |
|---|---|
| 1 month | −10.1% |
| 3 months | −20.0% |
| 6 months | −61.9% |
| 1 year | −70.0% |
| 3 years | +42.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.936 / 1.346 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.053 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.